Description
Added on the 17/02/2016 15:58:49 - Copyright : Reuters EN
A new analysis by the American Cancer Society reveals death from cancer in the United States fell 31% between 1991 and 2018. Nevertheless, the organization also estimates that this year, nearly 1.9 million people will be diagnosed with cancer and more than 600,000 will die from it. According to UPI, cancer remains the second-leading cause of death in the United States. Significant gains have been made in four of the deadliest and most common cancer, namely lung, breast, colorectal, and prostate. Lung cancer is still the most common cause of cancer death nationally. However, the data showed death rates for the disease fell 2.4% annually between 2009 and 2013 and 5% annually between 2014 and 2018.
The stricken seven-time Formula One world champion Michael Schumacher is in Paris' Georges-Pompidou hospital for cell therapy surgery, according to French daily Le Parisien. The Paris hospitals department, contacted by AFP, refused to confirm or deny the news citing medical privacy laws. IMAGES
Montevideo, Sep 30 (EFE) (CAMERA: Alejandro Prieto and Santiago Carbone). What happens if we look through the microscope at the skin of the bather who sunbathes at the beach, an innovative project of Uruguayan doctors and scientists to combat skin cancer.
Barcelona (Spain), ??Jan 28 (EFE).- (Camera: EFE) The Vall d'Hebron University Hospital in Barcelona studies the benefits of horse therapy in the recovery of children and adolescents who have suffered from cancer affecting the central nervous system.FOOTAGE OF THE SANT CUGAT DEL VALLES RIDING CENTRE IN BARCELONA AND A CANCER PATIENT.
Cincinnati Children’s Hospital Massive studies have shown great things, says Business Insider. Two leading coronavirus vaccines are highly effective at preventing people from getting COVID-19. Top researchers are already pitching plans for additional studies. This research aims to answer a critical question... Will this also prevent transmission of the virus? Many people wonder, particularly, about asymptomatic infections and carriers. Key barriers to these studies are getting funding and getting vaccine developers on board.
|
Support : Technical 
- Content 
- Editors 
